Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jianjun Yu

Showing results (301-310 of 325) with videos related to

Pageof 33
Sort By:
Frontiers in Oncology|September 10, 2021
Circulating Cell-Free DNA-Based Detection of Tumor Suppressor Gene Copy Number Loss and Its Clinical Implication in Metastatic Prostate CancerXiaoxi Dong, Tiantian Zheng, Minhua Zhang, et al.
Journal of Human Genetics|January 16, 2015
Exome sequencing identifies a novel CEACAM16 mutation associated with autosomal dominant nonsyndromic hearing loss DFNA4B in a Chinese familyHonghan Wang, Xinwei Wang, Chufeng He, et al.
European Urology|June 4, 2020
Combined Cell-free DNA and RNA Profiling of the Androgen Receptor: Clinical Utility of a Novel Multianalyte Liquid Biopsy Assay for Metastatic Prostate CancerHeidi Fettke, Edmond M Kwan, Maria M Docanto, et al.
Cancer Research|April 6, 2007
Autoantibody profiles reveal ubiquilin 1 as a humoral immune response target in lung adenocarcinomaGuoan Chen, Xiaoju Wang, Jianjun Yu, et al.
JCO Precision Oncology|July 12, 2021
Plasma Cell-Free DNA Profiling of PTEN-PI3K-AKT Pathway Aberrations in Metastatic Castration-Resistant Prostate CancerEdmond M Kwan, Chao Dai, Heidi Fettke, et al.
European Urology|September 8, 2021
Avelumab Combined with Stereotactic Ablative Body Radiotherapy in Metastatic Castration-resistant Prostate Cancer: The Phase 2 ICE-PAC Clinical TrialEdmond M Kwan, Lavinia Spain, Angelyn Anton, et al.
NPJ Breast Cancer|July 20, 2017
The molecular landscape of high-risk early breast cancer: comprehensive biomarker analysis of a phase III adjuvant populationTimothy R Wilson, Jianjun Yu, Xuyang Lu, et al.
Science (New York, N.Y.)|March 31, 2022
Bronze and Iron Age population movements underlie Xinjiang population historyVikas Kumar, Wenjun Wang, Jie Zhang, et al.
Cancer Cell|May 19, 2010
An integrated network of androgen receptor, polycomb, and TMPRSS2-ERG gene fusions in prostate cancer progressionJindan Yu, Jianjun Yu, Ram-Shankar Mani, et al.
Science Advances|April 1, 2021
Ancient Xinjiang mitogenomes reveal intense admixture with high genetic diversityWenjun Wang, Manyu Ding, Jacob D Gardner, et al.
Pageof 33

Showing results (301-310 of 325) with videos related to

Sort By:
Pageof 33
Frontiers in Oncology|September 10, 2021
Circulating Cell-Free DNA-Based Detection of Tumor Suppressor Gene Copy Number Loss and Its Clinical Implication in Metastatic Prostate CancerXiaoxi Dong, Tiantian Zheng, Minhua Zhang, et al.
Journal of Human Genetics|January 16, 2015
Exome sequencing identifies a novel CEACAM16 mutation associated with autosomal dominant nonsyndromic hearing loss DFNA4B in a Chinese familyHonghan Wang, Xinwei Wang, Chufeng He, et al.
European Urology|June 4, 2020
Combined Cell-free DNA and RNA Profiling of the Androgen Receptor: Clinical Utility of a Novel Multianalyte Liquid Biopsy Assay for Metastatic Prostate CancerHeidi Fettke, Edmond M Kwan, Maria M Docanto, et al.
Cancer Research|April 6, 2007
Autoantibody profiles reveal ubiquilin 1 as a humoral immune response target in lung adenocarcinomaGuoan Chen, Xiaoju Wang, Jianjun Yu, et al.
JCO Precision Oncology|July 12, 2021
Plasma Cell-Free DNA Profiling of PTEN-PI3K-AKT Pathway Aberrations in Metastatic Castration-Resistant Prostate CancerEdmond M Kwan, Chao Dai, Heidi Fettke, et al.
European Urology|September 8, 2021
Avelumab Combined with Stereotactic Ablative Body Radiotherapy in Metastatic Castration-resistant Prostate Cancer: The Phase 2 ICE-PAC Clinical TrialEdmond M Kwan, Lavinia Spain, Angelyn Anton, et al.
NPJ Breast Cancer|July 20, 2017
The molecular landscape of high-risk early breast cancer: comprehensive biomarker analysis of a phase III adjuvant populationTimothy R Wilson, Jianjun Yu, Xuyang Lu, et al.
Science (New York, N.Y.)|March 31, 2022
Bronze and Iron Age population movements underlie Xinjiang population historyVikas Kumar, Wenjun Wang, Jie Zhang, et al.
Cancer Cell|May 19, 2010
An integrated network of androgen receptor, polycomb, and TMPRSS2-ERG gene fusions in prostate cancer progressionJindan Yu, Jianjun Yu, Ram-Shankar Mani, et al.
Science Advances|April 1, 2021
Ancient Xinjiang mitogenomes reveal intense admixture with high genetic diversityWenjun Wang, Manyu Ding, Jacob D Gardner, et al.
Pageof 33